These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7492274)

  • 41. Effect of serum deprivation on constitutive production of granulocyte-colony stimulating factor and granulocyte macrophage-colony stimulating factor in lung cancer cells.
    Uemura Y; Kobayashi M; Nakata H; Harada R; Kubota T; Taguchi H
    Int J Cancer; 2004 May; 109(6):826-32. PubMed ID: 15027115
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Granulocyte-macrophage colony-stimulating factor potentiates antitumor activity of interleukin-12 in melanoma model in mice.
    Gołab J; Stokłosa T; Zagozdzon R; Kaca A; Kulchitska LA; Feleszko W; Kawiak J; Hoser G; Głowacka E; Dabrowska A; Giermasz A; Lasek W; Jakóbisiak M
    Tumour Biol; 1998; 19(2):77-87. PubMed ID: 9486559
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Action of granulopoiesis-stimulating cytokines rhG-CSF, rhGM-CSF, and rmGM-CSF on murine haematopoietic progenitor cells for granulocytes and macrophages (GM-CFC).
    Hofer M; Vacek A; Weiterová L
    Physiol Res; 2005; 54(2):207-13. PubMed ID: 15544422
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
    Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
    Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antifungal activities of posaconazole and granulocyte-macrophage colony-stimulating factor ex vivo and in mice with disseminated infection due to Scedosporium prolificans.
    Simitsopoulou M; Gil-Lamaignere C; Avramidis N; Maloukou A; Lekkas S; Havlova E; Kourounaki L; Loebenberg D; Roilides E
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3801-5. PubMed ID: 15388437
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neutralization of endogenous granulocyte-macrophage colony-stimulating factor subverts the protective immune response to Histoplasma capsulatum.
    Deepe GS; Gibbons R; Woodward E
    J Immunol; 1999 Nov; 163(9):4985-93. PubMed ID: 10528203
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dexamethasone prevents granulocyte-macrophage colony-stimulating factor-induced nuclear factor-kappaB activation, inducible nitric oxide synthase expression and nitric oxide production in a skin dendritic cell line.
    Vital AL; Gonçalo M; Cruz MT; Figueiredo A; Duarte CB; Lopes MC
    Mediators Inflamm; 2003 Apr; 12(2):71-8. PubMed ID: 12775356
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells.
    Winter JN; Lazarus HM; Rademaker A; Villa M; Mangan C; Tallman M; Jahnke L; Gordon L; Newman S; Byrd K; Cooper BW; Horvath N; Crum E; Stadtmauer EA; Conklin E; Bauman A; Martin J; Goolsby C; Gerson SL; Bender J; O'Gorman M
    J Clin Oncol; 1996 Jan; 14(1):277-86. PubMed ID: 8558209
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Up-regulation of granulocyte-macrophage colony-stimulating factor (GM-CSF) receptors in murine peritoneal exudate macrophages by both GM-CSF and IL-3.
    Fan K; Ruan Q; Sensenbrenner L; Chen BD
    J Immunol; 1992 Jul; 149(1):96-102. PubMed ID: 1535090
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Granulocyte-macrophage colony-stimulating factor modulates immune function and improves survival after experimental thermal injury.
    Molloy RG; Holzheimer R; Nestor M; Collins K; Mannick JA; Rodrick ML
    Br J Surg; 1995 Jun; 82(6):770-6. PubMed ID: 7627508
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of granulocyte-macrophage colony-stimulating factor in experimental visceral leishmaniasis.
    Murray HW; Cervia JS; Hariprashad J; Taylor AP; Stoeckle MY; Hockman H
    J Clin Invest; 1995 Mar; 95(3):1183-92. PubMed ID: 7883967
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Granulocyte-macrophage colony-stimulating factor (GM-CSF) enhances pulmonary defenses against pneumococcal infections after splenectomy.
    Hebert JC; O'Reilly M
    J Trauma; 1996 Oct; 41(4):663-6. PubMed ID: 8858025
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of exogenous recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor on neutrophil function following allogeneic bone marrow transplantation.
    Fabian I; Kletter Y; Bleiberg I; Gadish M; Naparsteck E; Slavin S
    Exp Hematol; 1991 Oct; 19(9):868-73. PubMed ID: 1716591
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies.
    Vose JM; Bierman PJ; Ruby E; Reed EC; Bishop MR; Tarantolo S; Kessinger A; Armitage JO
    Bone Marrow Transplant; 1996 Jun; 17(6):951-6. PubMed ID: 8807099
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy.
    Bregni M; Siena S; Di Nicola M; Dodero A; Peccatori F; Ravagnani F; Danesini G; Laffranchi A; Bonadonna G; Gianni AM
    J Clin Oncol; 1996 Feb; 14(2):628-35. PubMed ID: 8636780
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hemopoietic stem cell transplantation for lymphoma.
    Advani R; Chao NJ; Horning SJ; Blume KG; Ahn DK; Lamborn KR; Fleming NC; Bonnem EM; Greenberg PL
    Ann Intern Med; 1992 Feb; 116(3):183-9. PubMed ID: 1345803
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes.
    Suzuki H; Katayama N; Ikuta Y; Mukai K; Fujieda A; Mitani H; Araki H; Miyashita H; Hoshino N; Nishikawa H; Nishii K; Minami N; Shiku H
    Am J Hematol; 2004 Apr; 75(4):179-89. PubMed ID: 15054806
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
    Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y
    Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Production of IL-1 receptor antagonist by human in vitro-derived macrophages. Effects of lipopolysaccharide and granulocyte-macrophage colony-stimulating factor.
    Janson RW; Hance KR; Arend WP
    J Immunol; 1991 Dec; 147(12):4218-23. PubMed ID: 1836481
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF.
    Ballestrero A; Ferrando F; Garuti A; Basta P; Gonella R; Stura P; Mela GS; Sessarego M; Gobbi M; Patrone F
    J Clin Oncol; 1999 Apr; 17(4):1296. PubMed ID: 10561192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.